Overview
IMMX market data
Price History
IMMX price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for IMMX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Needham Initiates Coverage On Immix Biopharma with Buy Rating, Announces Price Target of $21Benzinga · Jul 22, 2026, 11:17 AM
Immix Biopharma shares are trading lower. A report suggested that a fugitive worked as an executive for the company.Benzinga · Jul 20, 2026, 7:43 PM
IMMX ALERT: Immix Biopharma Investigated for Securities Fraud Violations by Block & Leviton; Investors Should Contact the FirmGlobenewswire Inc · Jul 20, 2026, 4:15 PM
Watching Immix Biopharma; Shares Trading Lower, Traders Circulate STAT News Article Titled 'A Most-Wanted Fugitive Appears To Have Been Secretly Working As A Biotech Executive'Benzinga · Jul 20, 2026, 1:41 PM
8-K filing — Immix Biopharma, Inc. (IMMX)SEC EDGAR · Jul 20, 2026, 10:05 AM
Immix Biopharma Analyst Bullish But Flags Safety, Adoption QuestionsBenzinga · Jun 18, 2026, 5:40 PM
This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For ThursdayBenzinga · Jun 18, 2026, 12:15 PM
This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For ThursdayBenzinga · Jun 18, 2026, 11:50 AM
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common StockGlobenewswire Inc · May 22, 2026, 10:15 PM
HC Wainwright & Co. Maintains Buy on Immix Biopharma, Raises Price Target to $20Benzinga · May 22, 2026, 4:10 PM